Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a singl...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bab2b723715640b5ba9b5810747da43b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bab2b723715640b5ba9b5810747da43b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bab2b723715640b5ba9b5810747da43b2021-11-11T17:06:23ZCysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy10.3390/ijms2221116301422-00671661-6596https://doaj.org/article/bab2b723715640b5ba9b5810747da43b2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11630https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a single amino acid in the diet is difficult. However, the in vivo turnover rate of cysteine is usually higher than the rate of intake through food. For this reason, every cell can enzymatically synthesize cysteine from methionine, which enables the use of specific enzymatic inhibitors. In this work, we analysed the potential of cysteine restriction (CysR) in the murine cell line L929. This study determined metabolic fingerprints using mass spectrometry (LC/MS). The profiles were compared with profiles created in an earlier work under MetR. The study was supplemented by proliferation studies using D-amino acid analogues and inhibitors of intracellular cysteine synthesis. CysR showed a proliferation inhibition potential comparable to that of MetR. However, the metabolic footprints differed significantly and showed that CysR does not induce classic LEM at the metabolic level. Nevertheless, CysR offers great potential as an alternative for decisive interventions in general and tumour metabolism at the metabolic level.Werner SchmitzElena RiesCorinna KodererMaximilian Friedrich VölterAnna Chiara WünschMohamed El-MeseryKyra FrackmannAlexander Christian KüblerChristian LinzAxel SeherMDPI AGarticlemethionine restrictioncysteine restrictionmass spectrometryLC/MScancer therapycaloric restrictionBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11630, p 11630 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
methionine restriction cysteine restriction mass spectrometry LC/MS cancer therapy caloric restriction Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
methionine restriction cysteine restriction mass spectrometry LC/MS cancer therapy caloric restriction Biology (General) QH301-705.5 Chemistry QD1-999 Werner Schmitz Elena Ries Corinna Koderer Maximilian Friedrich Völter Anna Chiara Wünsch Mohamed El-Mesery Kyra Frackmann Alexander Christian Kübler Christian Linz Axel Seher Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
description |
Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to caloric restriction (CR). The implementation of MetR as a therapy for cancer or other diseases is not simple since the elimination of a single amino acid in the diet is difficult. However, the in vivo turnover rate of cysteine is usually higher than the rate of intake through food. For this reason, every cell can enzymatically synthesize cysteine from methionine, which enables the use of specific enzymatic inhibitors. In this work, we analysed the potential of cysteine restriction (CysR) in the murine cell line L929. This study determined metabolic fingerprints using mass spectrometry (LC/MS). The profiles were compared with profiles created in an earlier work under MetR. The study was supplemented by proliferation studies using D-amino acid analogues and inhibitors of intracellular cysteine synthesis. CysR showed a proliferation inhibition potential comparable to that of MetR. However, the metabolic footprints differed significantly and showed that CysR does not induce classic LEM at the metabolic level. Nevertheless, CysR offers great potential as an alternative for decisive interventions in general and tumour metabolism at the metabolic level. |
format |
article |
author |
Werner Schmitz Elena Ries Corinna Koderer Maximilian Friedrich Völter Anna Chiara Wünsch Mohamed El-Mesery Kyra Frackmann Alexander Christian Kübler Christian Linz Axel Seher |
author_facet |
Werner Schmitz Elena Ries Corinna Koderer Maximilian Friedrich Völter Anna Chiara Wünsch Mohamed El-Mesery Kyra Frackmann Alexander Christian Kübler Christian Linz Axel Seher |
author_sort |
Werner Schmitz |
title |
Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title_short |
Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title_full |
Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title_fullStr |
Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title_full_unstemmed |
Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy |
title_sort |
cysteine restriction in murine l929 fibroblasts as an alternative strategy to methionine restriction in cancer therapy |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/bab2b723715640b5ba9b5810747da43b |
work_keys_str_mv |
AT wernerschmitz cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT elenaries cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT corinnakoderer cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT maximilianfriedrichvolter cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT annachiarawunsch cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT mohamedelmesery cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT kyrafrackmann cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT alexanderchristiankubler cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT christianlinz cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy AT axelseher cysteinerestrictioninmurinel929fibroblastsasanalternativestrategytomethioninerestrictionincancertherapy |
_version_ |
1718432198800965632 |